Amyloid-β deposition in mild cognitive impairment is associated with increased hippocampal activity, atrophy and clinical progression
about
Cognitive reserve and lifestyle: moving towards preclinical Alzheimer's diseaseSpatial learning and memory impairments are associated with increased neuronal activity in 5XFAD mouse as measured by manganese-enhanced magnetic resonance imaging.Where is hippocampal activity in the cascade of Alzheimer's disease biomarkers?Prefrontal Lobe Brain Reserve Capacity with Resistance to Higher Global Amyloid Load and White Matter Hyperintensity Burden in Mild Stage Alzheimer's DiseaseGWAS of longitudinal amyloid accumulation on 18F-florbetapir PET in Alzheimer's disease implicates microglial activation gene IL1RAP.Constructing longitudinal disease progression curves using sparse, short-term individual data with an application to Alzheimer's disease.Preclinical properties and human in vivo assessment of 123I-ABC577 as a novel SPECT agent for imaging amyloid-β.Increased hippocampal activation in ApoE-4 carriers and non-carriers with amnestic mild cognitive impairment.Comparisons of neurodegeneration over time between healthy ageing and Alzheimer's disease cohorts via Bayesian inference.Hippocampal activation is associated with longitudinal amyloid accumulation and cognitive decline.Dissociating Normal Aging from Alzheimer's Disease: A View from Cognitive Neuroscience.Depressive Symptoms are Associated with Progression to Dementia in Patients with Amyloid-Positive Mild Cognitive Impairment.Comparison of Different Hypotheses Regarding the Spread of Alzheimer's Disease Using Markov Random Fields and Multimodal Imaging.Amyloid-Beta Deposition is Associated with Increased Medial Temporal Lobe Activation during Memory Encoding in the Cognitively Normal Elderly.Phases of Hyperconnectivity and Hypoconnectivity in the Default Mode and Salience Networks Track with Amyloid and Tau in Clinically Normal Individuals.Lower Cerebrospinal Fluid Concentration of Brain-Derived Neurotrophic Factor Predicts Progression from Mild Cognitive Impairment to Alzheimer's Disease.Epileptic activity in Alzheimer's disease: causes and clinical relevance.Targeting Neural Hyperactivity as a Treatment to Stem Progression of Late-Onset Alzheimer's Disease.The effect of hippocampal function, volume and connectivity on posterior cingulate cortex functioning during episodic memory fMRI in mild cognitive impairmentTau and β-Amyloid Are Associated with Medial Temporal Lobe Structure, Function, and Memory Encoding in Normal Aging.Left Frontal Hub Connectivity during Memory Performance Supports Reserve in Aging and Mild Cognitive Impairment.Epicenters of dynamic connectivity in the adaptation of the ventral visual system.Distinct spatiotemporal patterns of neuronal functional connectivity in primary progressive aphasia variants.Interactive versus additive relationships between regional cortical thinning and amyloid burden in predicting clinical decline in mild AD and MCI individuals.The hippocampal network model: A transdiagnostic metaconnectomic approach.The cerebellum in Alzheimer's disease: evaluating its role in cognitive decline.White Matter Hyperintensities Potentiate Hippocampal Volume Reduction in Non-Demented Older Individuals with Abnormal Amyloid-β.Heightened cortical excitability in aged rodents with memory impairment.Decreased hippocampal metabolism in high-amyloid mild cognitive impairment.Patients with Amyloid-Negative Mild Cognitive Impairment have Cortical Hypometabolism but the Hippocampus is Preserved.The association between hippocampal subfield volumes and education in cognitively normal older adults and amnestic mild cognitive impairment patients.Reduced grid-cell-like representations in adults at genetic risk for Alzheimer's disease.The complex link between amyloid and neuronal dysfunction in Alzheimer's disease.Association of Hippocampal Substructure Resting-State Functional Connectivity with Memory Performance in Older Adults.Neuropsychology and neuroimaging profiles of amyloid-positive versus amyloid-negative amnestic mild cognitive impairment patients.Radiomic Features of Hippocampal Subregions in Alzheimer's Disease and Amnestic Mild Cognitive ImpairmentMRI predictors of amyloid pathology: results from the EMIF-AD Multimodal Biomarker Discovery study
P2860
Q26796235-A5BE6712-4F5A-4FDD-9F3B-0D4ECF0AA05BQ31122548-1B53D028-5246-46A2-8DE2-5C25D1395D6AQ35626515-57F9E418-62E8-433C-BC8B-396987D56451Q35922689-FB9F71B8-54A6-419F-87F2-0831342B8F7EQ36351585-61523B8B-2477-41A4-A282-0707B36E640EQ36356412-C212BEA5-C924-4F3B-95A6-60983D016E03Q37104887-288A6855-8BBF-4456-A36C-A1E3221D298DQ37567356-DE395A00-9A97-4BF8-B861-06B699DCCA0BQ37639968-166E4A3F-46EB-4512-A527-F9F04C971A5AQ37665949-00E56046-4146-4635-941E-CF5B94555A20Q37721144-C838BF60-992D-4BD5-8C57-E4A32B578483Q38402481-AE05575D-31D9-441F-9FEA-A3801949FBB0Q38683925-94AB531E-F868-41D6-A5FC-53632317AB65Q38761575-E2BCCD8B-1765-4850-8BF3-E029D6DEFEA5Q38896981-CB7D33DD-20FB-4186-B5C4-331DB3EF6E9FQ38988833-15979049-50C4-470F-A69E-44EC664702ECQ39192571-2763095E-B108-493D-89FC-2A6EBDD2F61EQ39339952-E667EB26-B1CB-461E-B3E4-5357E3F12DCFQ41261064-0E734949-4F33-4190-A2DB-1FB6D96F498DQ41700392-B1313ADF-485F-4B83-B43A-3CF42BC5ABBDQ42363347-7ED92E18-A7D6-4EFF-ACC5-9099B38A507EQ46179277-25BD3175-F768-4712-B119-EC2845484D4CQ46837391-B497A769-0CBB-4B5E-ACA6-D986A23AD9CBQ47141267-345565B8-9DB6-47DB-AEAF-50B7B19EB8BAQ47553885-0DAFC6DC-7292-4AE7-842D-AE3A0BDFBABCQ47592930-C8BC2E6B-1EBC-40E3-9EBC-DBCC1FA71611Q47930258-CDE147FD-27EC-4835-87EE-D29F5D99E7D9Q48349276-094A2346-1631-4FA6-B0E8-7B2B533D5891Q48621788-35DD56ED-AB0D-4FD7-A07C-54FA6598B645Q48710914-10E0C0CB-BD49-4155-8CD3-0427C3BF5FC9Q49594142-02288827-5A51-45A6-825B-2CD541AFFC6BQ50553660-21DD3CD8-F649-437C-B6F8-806D0E71A7E0Q52146540-9462197E-D6BD-4410-BC61-539D648EBD63Q55139841-F868F004-F174-40AC-8D32-4729D6E0909DQ55234437-C6133303-BC81-4ABF-B50C-024BA09A00D6Q57491924-51BE2886-C242-443C-A0AA-C40E2D1C49EAQ59128613-BF8DA321-60B6-4F3C-A2B6-D1AF16B34313
P2860
Amyloid-β deposition in mild cognitive impairment is associated with increased hippocampal activity, atrophy and clinical progression
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Amyloid-β deposition in mild c ...... rophy and clinical progression
@ast
Amyloid-β deposition in mild c ...... rophy and clinical progression
@en
type
label
Amyloid-β deposition in mild c ...... rophy and clinical progression
@ast
Amyloid-β deposition in mild c ...... rophy and clinical progression
@en
prefLabel
Amyloid-β deposition in mild c ...... rophy and clinical progression
@ast
Amyloid-β deposition in mild c ...... rophy and clinical progression
@en
P2093
P2860
P50
P356
P1433
P1476
Amyloid-β deposition in mild c ...... rophy and clinical progression
@en
P2093
Dorene M Rentz
Elizabeth C Mormino
Gad A Marshall
Keith A Johnson
Mykol Larvie
Rebecca E Amariglio
Reisa A Sperling
Sarah Wigman
P2860
P304
P356
10.1093/BRAIN/AWV007
P407
P577
2015-02-11T00:00:00Z